Connect with us

Technology

Piezo Therapeutics Announces Formation of Scientific Advisory Board with Industry Veterans and Academic Luminaries

Published

on

World-renowned experts across infectious diseases, vaccines, and dermatology to advise Piezo on advancing its energy-based delivery platform and internal programs to the clinic

ATLANTA, April 21, 2025 /PRNewswire-PRWeb/ — Piezo Therapeutics, a biotechnology company pioneering energy-driven genetic medicines, announced today the formation of its Scientific Advisory Board (“SAB”) with leaders in infectious diseases, vaccines, and skin biology. The inaugural SAB will work closely with Piezo’s leadership team to provide technical insights and strategic guidance as Piezo advances its energy-based delivery platform (Piezopen) for its wholly owned programs and with pharma/biotech partners. Members of Piezo’s SAB bring decades of experience across RNA vaccines and therapeutics, DNA medicines, drug delivery, and dermatology.

“Our distinguished SAB will allow the company to continue its commitment to the highest-quality science focused on addressing unmet medical needs through energy-driven genetic medicines.” – Mark Prausnitz, PhD, Piezo co-founder and Regents’ Professor at Georgia Tech

“We are honored to welcome an illustrious group of industry veterans and academic leaders to our SAB as we advance Piezopen to the clinic,” said Gaurav Byagathvalli, CEO of Piezo. “Our SAB members have dedicated their careers to advancing novel medicines and deciphering human biology to prevent and cure life-threatening diseases. We look forward to drawing upon their deep expertise across multiple therapeutic areas as we advance our internal programs and ongoing collaborations towards first-in-human studies.”

Mark Prausnitz, PhD, Piezo co-founder and Regents’ Professor at Georgia Tech, added that “Piezo was founded on rigorous science and technology development at Georgia Tech. Our distinguished SAB will allow the company to continue its commitment to the highest-quality science focused on addressing unmet medical needs through energy-driven genetic medicines.”

The SAB includes (in alphabetical order):

Dr. Kate Broderick, PhD: Dr. Broderick has more than 20 years of experience in the life science industry. A recognized vaccine expert, Dr. Broderick has a broad background in device and product development in the DNA therapeutic and drug delivery field. Prior to joining Maravai in 2022 as the Chief Innovation Officer, Dr. Broderick held roles of increasing responsibility at Inovio Pharmaceuticals, most recently as Senior Vice President, R&D. Dr. Broderick has served as a principal investigator for a variety of grants and awards from government agencies and non-profits, including the National Institutes of Health. She received her PhD from the University of Glasgow in Scotland and completed her post-doctoral research at the University of California, San Diego.Dr. Elaine Fuchs, PhD: Dr. Fuchs is renowned for her research in skin biology, its stem cells and associated disorders, including cancers and inflammation. She is an Investigator of the Howard Hughes Medical Institute and has published >380 manuscripts. She received her PhD from Princeton in Biochemistry, her postdoctorate in Cell Biology at MIT, and has been on the faculty, first at University of Chicago and now Rockefeller University. Her awards include the National Medal of Science, L’Oreal-UNESCO Award, International Society for Stem Cell Research’s Innovation Award, the Gairdner International Award and the Franklin Medal. Dr. Fuchs holds membership in the National Academy of Sciences, National Academy of Medicine, American Philosophical Society, Pontifical Academy of Sciences, and the Royal Society. She is an inaugural member of the Academy of the American Association for Cancer Research, and now serves as its President.Dr. Norbert Pardi, PhD: Dr. Pardi holds a PhD in biochemistry and genetics from the University of Szeged, Hungary. He has been working at the University of Pennsylvania since 2011 and currently holds an Associate Professor position at the Department of Microbiology of the Perelman School of Medicine. He received training from Drs. Katalin Kariko and Drew Weissman at the University of Pennsylvania before he started his laboratory. His research interest is the development of mRNA-based therapeutics with particular focus on new-generation infectious disease vaccines. He explored the development of a novel vaccine platform using nucleoside-modified mRNA in lipid nanoparticles (LNPs) and used it to generate highly effective vaccines targeting various pathogens (influenza virus, coronaviruses, malaria and others). Dr. Pardi is a pioneer of the nucleoside-modified mRNA vaccine technology and published milestone papers in the field.Dr. Jeffrey Ulmer, PhD: Dr. Ulmer spent more than 30 years in vaccines R&D at Merck Research Laboratories, Chiron Corporation, Novartis and GlaxoSmithKline. His most recent leadership positions included Global Head, External R&D; Head, Preclinical R&D; and Program Head, Technical R&D. His scientific focus has been vaccine technology platforms, including DNA and mRNA vaccines, viral vectors and adjuvants. He received his Ph.D. in biochemistry from McGill University and a postdoctoral fellowship in the laboratory of Nobel laureate Dr. George Palade in the Department of Cell Biology at Yale University School of Medicine. He has published over 220 scientific articles, is an inventor on 11 patents, and is a Fellow of the International Society for Vaccines, where he serves as Vice-Chair of the Executive Board. He is currently President and CEO of TechImmune LLC, a biotechnology company based in Newport Beach, CA.

About Piezopen Platform

Our proprietary Piezopen platform enables localized yet highly efficient delivery of RNA and DNA without the need for lipid nanoparticles or viral vectors, with applications in infectious disease, cancer, chronic disease, and dermatology. In preclinical models, we have demonstrated robust induction of humoral and cellular responses to infectious disease and cancer vaccines with increased tolerability, dosing flexibility, and payload versatility. In human subjects, Piezopen was well accepted and shown to elicit superior tolerability compared to a hypodermic needle. Piezopen combines two innovations to surpass the limitations of formulations: piezoelectric pulses and microelectrodes for energy-based nucleic acid delivery. Piezopen improves the tolerability and efficacy of RNA/DNA medicines while slashing costs, simplifying manufacturing, and transforming scalability.

About Piezo Therapeutics

Piezo Therapeutics is a spinout from Georgia Tech focused on enabling next-gen nucleic acid vaccines and therapeutics via energy-based delivery. Integrating innovations in drug delivery and genetic medicine, Piezo is advancing its delivery platform and investigational therapeutics in collaboration with global pharma and biotech companies to prevent and treat debilitating diseases. The company raised its initial financing in 2023 backed by Good Ventures. For more information, please visit www.piezotx.com.

Media Contact

Gaurav Byagathvalli, Piezo Therapeutics, 1 4049973263, partnerships@piezotx.com, www.piezotx.com

View original content to download multimedia:https://www.prweb.com/releases/piezo-therapeutics-announces-formation-of-scientific-advisory-board-with-industry-veterans-and-academic-luminaries-302429880.html

SOURCE Piezo Therapeutics

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BinBase Expands 2026 BIN Dataset with Instant Payout Intelligence for iGaming, Gambling, and Cross-Border Transfers

Published

on

By

BinBase updates its 2026 dataset with specialized Fast Funds, Visa Direct, and Mastercard MoneySend indicators to help iGaming operators and payout platforms execute seamless, instant card disbursements.

MIAMI, July 23, 2026 /PRNewswire-PRWeb/ — BinBase, a global provider of payment routing intelligence and card issuing data, has introduced specialized instant payout indicators as part of its upgraded 2026 BIN Database. Tailored for iGaming operators, online gambling platforms, crypto-to-fiat ramps, and payout aggregators, the updated dataset helps platform engineers streamline real-time card disbursements and Push-to-Card (P2C) transactions.

In high-velocity sectors such as online betting and gaming, instantaneous player payouts are a primary driver of customer retention. However, executing Push-to-Card transactions through protocols like Visa Direct and Mastercard MoneySend requires knowing whether the receiving card issuer supports Fast Funds for specific merchant category codes (MCCs). Attempting instant payouts on non-eligible cards leads to declined transactions, elevated processing fees, and poor user experiences.

The 2026 BinBase release solves this operational bottleneck by delivering dedicated attributes for real-time fund disbursements:

Fast Funds Eligibility: Granular indicators identifying domestic and cross-border Fast Funds support across global Visa and Mastercard ranges.Online Gambling Fast Funds (OG FF): Dedicated flags specifically identifying card ranges authorized to receive real-time gambling and betting payouts.Mastercard MoneySend & Visa Direct Indicators: Precise protocol compatibility markers (MS Ind & MT Ind) ensuring push transactions are routed only to eligible recipient cards.Direct Debit & Pull-Funds Support: Indicators for recurring collections and account-funding transactions.

“Player payouts in iGaming cannot wait for standard 2-to-3-day ACH settlements,” said a spokesperson for Damiko Inc. “By embedding our Fast Funds and Gambling FF flags into their payment engines, operators can instantly validate recipient cards before initiating a transfer, guaranteeing high success rates and instant liquidity for their users.”

Fintech engineers and payout architects can examine the full 29-field database schema and access a free 2026 sample dataset on GitHub.

To explore commercial licensing, bulk database downloads, or custom data feeds, visit BinBase at https://binbase.com.

About Damiko Inc

Damiko Inc is a US-based fintech data provider specializing in card issuer analytics, payment routing data, and global BIN database solutions. Operating through its flagship product, BinBase.com, the company supplies high-precision transaction intelligence to help merchants and payment facilitators worldwide optimize approval rates and mitigate processing fees.

Media Contact
Fedor Lavrikoff, BinBase, 1 7866133334, sales@binbase.com, www.binbase.com 

View original content:https://www.prweb.com/releases/binbase-expands-2026-bin-dataset-with-instant-payout-intelligence-for-igaming-gambling-and-cross-border-transfers-302829344.html

SOURCE BinBase

Continue Reading

Technology

Walnut Coding’s Young Coders Serve as ‘Instructors’ at Huawei Cloud Developer Training Camp

Published

on

By

Ages 8 and 15, students showcase AI-era project-building skills from concept to working application

BEIJING, July 23, 2026 /PRNewswire/ — Walnut Coding (the “Company”), a leading online platform for youth coding education, said two of its students – ages 8 and 15 – have joined the “instructor” lineup at Huawei Cloud Developer Training Camp, making them among the youngest “instructors” in the program’s history. The Company cites the pair as a prime example of how young learners can combine coding fundamentals with AI tools to turn ideas into working applications.

The two students, Bolin Du, 8, and Peiqi Gao, 15, built working applications using Huawei Cloud CodeArts, an AI coding assistant, then presented the projects to the training camp themselves – walking the audience through their design choices, technical builds, and debugging process.

The move lands at a moment when AI coding tools are forcing a rethink across the education sector. Tools that can generate functioning code from a plain-language prompt have undercut the traditional argument for teaching children to program – that they need the skill to build things themselves. Walnut Coding’s answer is that the more valuable skill now is judgment – knowing what problem to solve, breaking it into parts, and determining whether an AI’s output actually works.

Gao built a travel-planning application that generates routes, itineraries, and recommendations based on user input, handling the project end to end, from requirements and design through coding and debugging. Du, the younger of the two, built an interactive calendar application, using HTML for page structure, CSS for visual design, and JavaScript for interactive features. Both students then took on an instructor’s role at the camp, presenting their project goals and technical implementation to the audience – a step Walnut Coding says separated the work from a typical classroom assignment.

These were not classroom exercises but working projects, built and presented inside a professional developer-training environment. The experience demanded more from both students than simply producing something functional – they needed to articulate their reasoning, defend technical choices, and refine the final result under scrutiny. Their participation signals a broader shift underway in what youth coding education can deliver.

AI is making code generation easier, but it is also redrawing which skills actually matter. A student who relies only on one-click generation may get a rough prototype quickly, but still struggle to spot logical flaws, judge whether the output is reliable, or turn an abstract idea into a product that actually works. Students with programming foundations, by contrast, are better positioned to define requirements, evaluate what the AI produces, correct its errors, and treat the technology as a tool rather than a shortcut to lean on.

“AI can help children generate code faster, but it cannot decide for them what problem they should solve, nor can it make the final judgment about whether the result is truly effective,” said Pengxuan Zeng, founder and CEO of Walnut Coding. “What these two students demonstrated is not just coding technique, but the ability to define needs, break down tasks, verify outcomes, and turn an idea into a working product. That is why we believe young people still need to learn programming in the AI era.”

Walnut Coding structures its courses around that thesis, pairing student-led project work with teaching-assistant guidance and AI-assisted support. According to the Company, this data is continuously fed back into its systems to refine the personalization of AI-assisted feedback — a closed-loop process linking teaching, practice, feedback, and curriculum development.

The Company frames the payoffs less around producing professional software engineers than around a broader form of literacy. As AI continues to reshape how tasks get done, the ability to understand the technology, structure problems clearly and collaborate effectively with intelligent tools may prove one of the most durable skills a young learner can develop.

Walnut Coding says it plans to keep expanding opportunities for students to build practical projects, partner with industry technology platforms such as Huawei Cloud, and develop the core capabilities needed to build with technology in the AI era.

View original content:https://www.prnewswire.com/news-releases/walnut-codings-young-coders-serve-as-instructors-at-huawei-cloud-developer-training-camp-302833884.html

SOURCE Walnut Coding

Continue Reading

Technology

MOREH Showcases High-Performance LLM Inference on AMD GPUs at AMD Advancing AI 2026

Published

on

By

SAN FRANCISCO, July 23, 2026 /PRNewswire/ — Moreh, an AI infrastructure software company, led by CEO Gangwon Jo, participated in AMD Advancing AI 2026, AMD’s flagship annual AI event held in San Francisco on July 22–23 (local time), where it demonstrated its distributed inference solution, the MoAI Inference Framework, running on AMD GPUs.

At the event, Moreh presented a live demonstration of the GLM-5.1 large language model (LLM) powered by the MoAI Inference Framework on a system equipped with 32 AMD Instinct™ MI300X GPUs across four nodes. Visitors experienced the chatbot firsthand, evaluating its response speed and service quality while observing performance across a range of real-world use cases.

Unlike conventional demonstrations that simply run an AI model, Moreh’s showcase displayed key inference service metrics in real time, including GPU utilization, Tokens Per Second (TPS), Time To First Token (TTFT), and Time Per Output Token (TPOT). This enabled attendees to directly verify both inference performance and GPU resource efficiency in a production-like service environment.

Global AI industry leaders and enterprise customers attending the event expressed strong interest in the system’s fast response times and stable performance. In particular, the live deployment of the computationally demanding GLM-5.1 model on AMD GPUs at production-grade service levels received positive feedback from visitors.

Moreh’s MoAI Inference Framework is widely recognized as the world’s first commercially deployed distributed inference solution built for the AMD ecosystem. Its distributed inference and heterogeneous computing technologies are designed to dramatically reduce AI service costs, enabling broader adoption of AI worldwide. The technology addresses one of the industry’s biggest challenges-the rapidly rising infrastructure and service costs caused by increasingly larger AI models-by delivering a more efficient inference infrastructure.

Moreh CEO Gangwon Jo stated, “This event provided an opportunity for global customers to verify firsthand that top-tier inference performance can be achieved on AMD GPU environments,” and added “We will continue advancing our AI infrastructure software so enterprises can operate AI services as efficiently as possible, regardless of the underlying GPU platform.”

Moreh develops its own AI infrastructure engine and has expanded its end-to-end AI capabilities through its foundation LLM subsidiary, Motif Technologies, covering both AI infrastructure and foundation models. The company is also strengthening its presence in the global AI market through strategic partnerships with leading technology companies, including AMD and Tenstorrent.

View original content to download multimedia:https://www.prnewswire.com/news-releases/moreh-showcases-high-performance-llm-inference-on-amd-gpus-at-amd-advancing-ai-2026-302833887.html

SOURCE Moreh

Continue Reading

Trending